Clinical Trial: Intranasal Insulin for COVID-19-related Smell Loss
Study Status: Completed
Recruit Status: Completed
Condition:
Anosmia
Smell Loss
Paraosmia
Hyposmia
COVID-19
Study Type: Interventional
Official Title: Intranasal Insulin for COVID-19-related Smell Loss
Brief Summary:
The aim of this study was to quantify the improvement in olfaction of 27 post-COVID-19 patients, after three intreventions of intranasal insulin during a four week period, with the help of the Threshold, Discrimination and Identification (TDI) score evaluated with Sniffin Sticks®.
Read more